Immune optimization
Showing 1 - 25 of >10,000
Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)
Recruiting
- Obesity
- Immune Deficiency
- Institutional standard intravenous immune globulin treatment
-
Somerville, New JerseyRobert Wood Johnson University Hospital Somerset
Oct 10, 2022
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
Optimization of Psoriatic and Seronegative Rheumatoid Arthritis
Recruiting
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Phenotyping of synovial immune and stromal cells
-
Rome, Italy
- +1 more
Mar 2, 2023
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone
Active, not recruiting
- Last Period Not Earlier Than 6 Months Ago
- oral menopausal hormone therapy
- transdermal menopausal hormone therapy
-
Moscow, Russian FederationFederal State Budget Institution Research Center for Obstetrics,
Jan 9, 2023
Optimization of Morphomer-based Alpha-synuclein PET Tracers
Completed
- Parkinson Disease
- +4 more
-
Lund, Skåne, SwedenSkåne University Hospital, Dept of Neurology
Sep 23, 2021
Kidney Transplant, Immunosuppression, Allograft Trial (KidneyCare, steroid, MMF)
Not yet recruiting
- Kidney Transplant
- +2 more
- KidneyCare
- +2 more
- (no location specified)
Jun 22, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Tirelizumab
- +3 more
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai jiaotong university school of medicine
Nov 6, 2023
Sample Collection From Healthy Volunteers for Assay Optimization
Recruiting
- Healthy Volunteers
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 1, 2022
IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- (no location specified)
Oct 27, 2023
Non Small Cell Lung Cancer Trial in Bayonne, Bordeaux, Pau (ICI treatment discontinuation, ICI treatment continuation)
Recruiting
- Non Small Cell Lung Cancer
- ICI treatment discontinuation
- ICI treatment continuation
-
Bayonne, France
- +4 more
Jul 27, 2022
Cholera, Cholera Vaccine Toxicity Trial in Boston (PanChol)
Recruiting
- Cholera
- Cholera Vaccine Toxicity
- PanChol
-
Boston, MassachusettsBrigham and Women's Hospital Vaccine Unit
Dec 11, 2022
Heart Failure, Gut Microbiome, Nutritional Deficiency Trial in New York (Ensure Surgery Immunonutrition shake)
Recruiting
- Heart Failure
- +2 more
- Ensure Surgery Immunonutrition shake
-
New York, New YorkColumbia University Medical Center
Dec 9, 2022
Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)
Recruiting
- Chronic Hepatitis B
- continuous treatment
- pulse therapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 13, 2022
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Defining Impact of Initial Influenza Exposure on Immunity in
Recruiting
- Influenza
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 23, 2022
HIV/AIDS Trial in San Francisco (PrEP Optimization Intervention (PrEP-OI))
Completed
- HIV/AIDS
- PrEP Optimization Intervention (PrEP-OI)
-
San Francisco, CaliforniaUCSF Center for AIDS Prevention Studies
Jun 28, 2022
Bladder Cancer, Bacillus Calmette-Guerin Trial in Campinas (Bacillus Calmette Guerin, PLACEBO)
Active, not recruiting
- Bladder Cancer
- Bacillus Calmette-Guerin
- Bacillus Calmette Guerin
- PLACEBO
-
Campinas, SP, BrazilHospital das Clínicas Unicamp
May 18, 2022
Primary Immunodeficiency Disease Trial (IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- IVIG
- (no location specified)
Oct 16, 2023
Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and
Active, not recruiting
- Glioblastoma Multiforme
- +3 more
- IMA950/Poly-ICLC
- IMA950/Poly-ICLC and pembrolizumab
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Dec 23, 2022
Asthma in Children, Sleep Hygiene, Sleep, Inadequate Trial in Providence (Shortened Sleep, Stabilized sleep)
Recruiting
- Asthma in Children
- +2 more
- Shortened Sleep
- Stabilized sleep
-
Providence, Rhode IslandRhode Island Hospital
Jun 13, 2022
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- Multiple Myeloma
- Best Practice
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 19, 2023
Selinexor Combined With Lenalidomide and Rituximab in Treatment
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse
- Selinexor combined with lenalidomide and rituximab
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 20, 2023